Microfluidic Formulation of DNA-Loaded Multicomponent Lipid Nanoparticles for Gene Delivery

In recent years, lipid nanoparticles (LNPs) have gained considerable attention in numerous research fields ranging from gene therapy to cancer immunotherapy and DNA vaccination. While some RNA-encapsulating LNP formulations passed clinical trials, DNA-loaded LNPs have been only marginally explored s...

Full description

Bibliographic Details
Main Authors: Erica Quagliarini, Serena Renzi, Luca Digiacomo, Francesca Giulimondi, Barbara Sartori, Heinz Amenitsch, Valentina Tassinari, Laura Masuelli, Roberto Bei, Lishan Cui, Junbiao Wang, Augusto Amici, Cristina Marchini, Daniela Pozzi, Giulio Caracciolo
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/13/8/1292
id doaj-a4bdbd952b574c60976f3fdea73c3bc7
record_format Article
spelling doaj-a4bdbd952b574c60976f3fdea73c3bc72021-08-26T14:13:21ZengMDPI AGPharmaceutics1999-49232021-08-01131292129210.3390/pharmaceutics13081292Microfluidic Formulation of DNA-Loaded Multicomponent Lipid Nanoparticles for Gene DeliveryErica Quagliarini0Serena Renzi1Luca Digiacomo2Francesca Giulimondi3Barbara Sartori4Heinz Amenitsch5Valentina Tassinari6Laura Masuelli7Roberto Bei8Lishan Cui9Junbiao Wang10Augusto Amici11Cristina Marchini12Daniela Pozzi13Giulio Caracciolo14Department of Chemistry, “Sapienza” University of Rome, 00185 Rome, ItalyDepartment of Molecular Medicine, “Sapienza” University of Rome, 00161 Rome, ItalyDepartment of Molecular Medicine, “Sapienza” University of Rome, 00161 Rome, ItalyDepartment of Molecular Medicine, “Sapienza” University of Rome, 00161 Rome, ItalyInstitute of inorganic Chemistry, Graz University of Technology, 8010 Graz, AustriaInstitute of inorganic Chemistry, Graz University of Technology, 8010 Graz, AustriaDepartment of Molecular Medicine, “Sapienza” University of Rome, 00161 Rome, ItalyDepartment of Experimental Medicine, “Sapienza” University of Rome, 00185 Rome, ItalyDepartment of Clinical Sciences and Translational Medicine, University of Rome “Tor Vergata”, 00133 Rome, ItalySchool of Biosciences and Veterinary Medicine, University of Camerino, 62032 Camerino, ItalySchool of Biosciences and Veterinary Medicine, University of Camerino, 62032 Camerino, ItalySchool of Biosciences and Veterinary Medicine, University of Camerino, 62032 Camerino, ItalySchool of Biosciences and Veterinary Medicine, University of Camerino, 62032 Camerino, ItalyDepartment of Molecular Medicine, “Sapienza” University of Rome, 00161 Rome, ItalyDepartment of Molecular Medicine, “Sapienza” University of Rome, 00161 Rome, ItalyIn recent years, lipid nanoparticles (LNPs) have gained considerable attention in numerous research fields ranging from gene therapy to cancer immunotherapy and DNA vaccination. While some RNA-encapsulating LNP formulations passed clinical trials, DNA-loaded LNPs have been only marginally explored so far. To fulfil this gap, herein we investigated the effect of several factors influencing the microfluidic formulation and transfection behavior of DNA-loaded LNPs such as PEGylation, total flow rate (TFR), concentration and particle density at the cell surface. We show that PEGylation and post-synthesis sample concentration facilitated formulation of homogeneous and small size LNPs with high transfection efficiency and minor, if any, cytotoxicity on human Embryonic Kidney293 (HEK-293), spontaneously immortalized human keratinocytes (HaCaT), immortalized keratinocytes (N/TERT) generated from the transduction of human primary keratinocytes, and epidermoid cervical cancer (CaSki) cell lines. On the other side, increasing TFR had a detrimental effect both on the physicochemical properties and transfection properties of LNPs. Lastly, the effect of particle concentration at the cell surface on the transfection efficiency (TE) and cell viability was largely dependent on the cell line, suggesting that its case-by-case optimization would be necessary. Overall, we demonstrate that fine tuning formulation and microfluidic parameters is a vital step for the generation of highly efficient DNA-loaded LNPs.https://www.mdpi.com/1999-4923/13/8/1292lipid nanoparticlesmicrofluidicstransfection efficiencylipofectamine
collection DOAJ
language English
format Article
sources DOAJ
author Erica Quagliarini
Serena Renzi
Luca Digiacomo
Francesca Giulimondi
Barbara Sartori
Heinz Amenitsch
Valentina Tassinari
Laura Masuelli
Roberto Bei
Lishan Cui
Junbiao Wang
Augusto Amici
Cristina Marchini
Daniela Pozzi
Giulio Caracciolo
spellingShingle Erica Quagliarini
Serena Renzi
Luca Digiacomo
Francesca Giulimondi
Barbara Sartori
Heinz Amenitsch
Valentina Tassinari
Laura Masuelli
Roberto Bei
Lishan Cui
Junbiao Wang
Augusto Amici
Cristina Marchini
Daniela Pozzi
Giulio Caracciolo
Microfluidic Formulation of DNA-Loaded Multicomponent Lipid Nanoparticles for Gene Delivery
Pharmaceutics
lipid nanoparticles
microfluidics
transfection efficiency
lipofectamine
author_facet Erica Quagliarini
Serena Renzi
Luca Digiacomo
Francesca Giulimondi
Barbara Sartori
Heinz Amenitsch
Valentina Tassinari
Laura Masuelli
Roberto Bei
Lishan Cui
Junbiao Wang
Augusto Amici
Cristina Marchini
Daniela Pozzi
Giulio Caracciolo
author_sort Erica Quagliarini
title Microfluidic Formulation of DNA-Loaded Multicomponent Lipid Nanoparticles for Gene Delivery
title_short Microfluidic Formulation of DNA-Loaded Multicomponent Lipid Nanoparticles for Gene Delivery
title_full Microfluidic Formulation of DNA-Loaded Multicomponent Lipid Nanoparticles for Gene Delivery
title_fullStr Microfluidic Formulation of DNA-Loaded Multicomponent Lipid Nanoparticles for Gene Delivery
title_full_unstemmed Microfluidic Formulation of DNA-Loaded Multicomponent Lipid Nanoparticles for Gene Delivery
title_sort microfluidic formulation of dna-loaded multicomponent lipid nanoparticles for gene delivery
publisher MDPI AG
series Pharmaceutics
issn 1999-4923
publishDate 2021-08-01
description In recent years, lipid nanoparticles (LNPs) have gained considerable attention in numerous research fields ranging from gene therapy to cancer immunotherapy and DNA vaccination. While some RNA-encapsulating LNP formulations passed clinical trials, DNA-loaded LNPs have been only marginally explored so far. To fulfil this gap, herein we investigated the effect of several factors influencing the microfluidic formulation and transfection behavior of DNA-loaded LNPs such as PEGylation, total flow rate (TFR), concentration and particle density at the cell surface. We show that PEGylation and post-synthesis sample concentration facilitated formulation of homogeneous and small size LNPs with high transfection efficiency and minor, if any, cytotoxicity on human Embryonic Kidney293 (HEK-293), spontaneously immortalized human keratinocytes (HaCaT), immortalized keratinocytes (N/TERT) generated from the transduction of human primary keratinocytes, and epidermoid cervical cancer (CaSki) cell lines. On the other side, increasing TFR had a detrimental effect both on the physicochemical properties and transfection properties of LNPs. Lastly, the effect of particle concentration at the cell surface on the transfection efficiency (TE) and cell viability was largely dependent on the cell line, suggesting that its case-by-case optimization would be necessary. Overall, we demonstrate that fine tuning formulation and microfluidic parameters is a vital step for the generation of highly efficient DNA-loaded LNPs.
topic lipid nanoparticles
microfluidics
transfection efficiency
lipofectamine
url https://www.mdpi.com/1999-4923/13/8/1292
work_keys_str_mv AT ericaquagliarini microfluidicformulationofdnaloadedmulticomponentlipidnanoparticlesforgenedelivery
AT serenarenzi microfluidicformulationofdnaloadedmulticomponentlipidnanoparticlesforgenedelivery
AT lucadigiacomo microfluidicformulationofdnaloadedmulticomponentlipidnanoparticlesforgenedelivery
AT francescagiulimondi microfluidicformulationofdnaloadedmulticomponentlipidnanoparticlesforgenedelivery
AT barbarasartori microfluidicformulationofdnaloadedmulticomponentlipidnanoparticlesforgenedelivery
AT heinzamenitsch microfluidicformulationofdnaloadedmulticomponentlipidnanoparticlesforgenedelivery
AT valentinatassinari microfluidicformulationofdnaloadedmulticomponentlipidnanoparticlesforgenedelivery
AT lauramasuelli microfluidicformulationofdnaloadedmulticomponentlipidnanoparticlesforgenedelivery
AT robertobei microfluidicformulationofdnaloadedmulticomponentlipidnanoparticlesforgenedelivery
AT lishancui microfluidicformulationofdnaloadedmulticomponentlipidnanoparticlesforgenedelivery
AT junbiaowang microfluidicformulationofdnaloadedmulticomponentlipidnanoparticlesforgenedelivery
AT augustoamici microfluidicformulationofdnaloadedmulticomponentlipidnanoparticlesforgenedelivery
AT cristinamarchini microfluidicformulationofdnaloadedmulticomponentlipidnanoparticlesforgenedelivery
AT danielapozzi microfluidicformulationofdnaloadedmulticomponentlipidnanoparticlesforgenedelivery
AT giuliocaracciolo microfluidicformulationofdnaloadedmulticomponentlipidnanoparticlesforgenedelivery
_version_ 1721190689458356224